BREAST CANCER THERAPY: NEW TREATMENT METHODS FOR BREAST CANCER
Keywords:
Keywords: breast cancer, new treatments, immunotherapy, targeted therapy, personalized medicine, oncology, clinical trials, cancer therapyAbstract
Annotation: This article explores recent advancements in the treatment of breast
cancer, focusing on innovative therapeutic approaches such as immunotherapy,
targeted therapy, and personalized medicine. The study reviews clinical trials and
scientific literature to highlight how these new methods improve patient outcomes,
reduce side effects, and enhance survival rates. By comparing traditional treatments
with modern techniques, the article provides insight into the evolving landscape of
breast cancer management and outlines future directions in oncological care.
References
References:
1. Bower, M., Dalla Pria, A., Coyle, C., & Nelson, M. (2014). Prospective stage-
stratified approach to AIDS-related Kaposi’s sarcoma. Journal of Clinical
Oncology, 32(5), 409–414. https://doi.org/10.1200/JCO.2013.50.0392
2. Krown, S. E., Metroka, C., & Wernz, J. C. (1989). Kaposi’s sarcoma in the acquired
immune deficiency syndrome: A proposal for uniform evaluation, response, and
staging criteria. Journal of Clinical Oncology, 7(9), 1201–1207.
https://doi.org/10.1200/JCO.1989.7.9.1201
3. Polizzotto, M. N., Uldrick, T. S., Wyvill, K. M., Aleman, K., Peer, C. J., Kovacs, J.
A., … & Little, R. F. (2016). Pomalidomide for symptomatic Kaposi’s sarcoma in
people with and without HIV infection: A phase I/II study. Journal of Clinical
Oncology, 34(34), 4125–4131. https://doi.org/10.1200/JCO.2016.69.3501
4. Sullivan, R. J., Lutzky, J., Nguyen, K. B., Parker, S., Rinne, M. L., Chen, S., … &
Chmielowski, B. (2020). Nivolumab in Kaposi sarcoma: Safety and efficacy in a
multicenter, open-label, phase 2 study. The Lancet Oncology, 21(8), 1029–1039.
https://doi.org/10.1016/S1470-2045(20)30225-5
5. Uldrick, T. S., & Whitby, D. (2011). Update on KSHV epidemiology, Kaposi
sarcoma pathogenesis, and treatment of Kaposi sarcoma. Cancer Letters, 305(2),
